Search Results - "Kushal, Swati"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    In vivo anticancer activity of rhomboidal Pt(II) metallacycles by Grishagin, Ivan V., Pollock, J. Bryant, Kushal, Swati, Cook, Timothy R., Stang, Peter J., Olenyuk, Bogdan Z.

    “…Significance The design of new antitumor agents and the search for delivery vehicles for existing drugs are two problems in cancer therapy that are often…”
    Get full text
    Journal Article
  2. 2

    Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling by Kushal, Swati, Lao, Brooke Bullock, Henchey, Laura K., Dubey, Ramin, Mesallati, Hanah, Traaseth, Nathaniel J., Olenyuk, Bogdan Z., Arora, Paramjit S.

    “…Selective blockade of gene expression by designed small molecules is a fundamental challenge at the interface of chemistry, biology, and medicine…”
    Get full text
    Journal Article
  3. 3

    Suppression of Tumor Growth by Designed Dimeric Epidithiodiketopiperazine Targeting Hypoxia-Inducible Transcription Factor Complex by Dubey, Ramin, Levin, Michael D, Szabo, Lajos Z, Laszlo, Csaba F, Kushal, Swati, Singh, Jason B, Oh, Philip, Schnitzer, Jan E, Olenyuk, Bogdan Z

    Published in Journal of the American Chemical Society (20-03-2013)
    “…Hypoxia is a hallmark of solid tumors, is associated with local invasion, metastatic spread, resistance to chemo- and radiotherapy, and is an independent,…”
    Get full text
    Journal Article
  4. 4

    Streamlining the Detection of FLT3 Internal Tandem Duplication (FLT3-ITD) Using the Cepheid Genexpert® Automated System by Sirajuddin, Paul, Gregory, Austin, Kushal, Swati, Day, Gwo-Jen

    Published in Blood (02-11-2023)
    “…Objectives: The development of targeted therapies for Acute Myeloid leukemia (AML) demands fast and reliable diagnostic tests. Specifically, FMS-like tyrosine…”
    Get full text
    Journal Article
  5. 5

    Development of a Fast and Quantitative FLT3-TKD Mutation Prototype Using Lab in a Cartridge™ Technology by Kushal, Swati, Calayag, Kyle, Das, Suvarthi, Saatian, Behnaz, Xie, Guanyi, Bates, Michael, Day, Gwo-Jen

    Published in Blood (02-11-2023)
    “…Introduction Acute myeloid leukemia (AML) is a heterogenous hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the…”
    Get full text
    Journal Article
  6. 6

    Monoamine Oxidase A Inhibitor–Near-Infrared Dye Conjugate Reduces Prostate Tumor Growth by Wu, Jason Boyang, Lin, Tzu-Ping, Gallagher, John D, Kushal, Swati, Chung, Leland W. K, Zhau, Haiyen E, Olenyuk, Bogdan Z, Shih, Jean C

    Published in Journal of the American Chemical Society (18-02-2015)
    “…Development of anti-cancer agents with high tumor-targeting specificity and efficacy is critical for modern multidisciplinary cancer research. Monoamine…”
    Get full text
    Journal Article
  7. 7

    Inhibition of Hypoxia Inducible Factor 1Transcription Coactivator Interaction by a Hydrogen Bond Surrogate α-Helix by Henchey, Laura K, Kushal, Swati, Dubey, Ramin, Chapman, Ross N, Olenyuk, Bogdan Z, Arora, Paramjit S

    Published in Journal of the American Chemical Society (27-01-2010)
    “…Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the…”
    Get full text
    Journal Article
  8. 8

    Monoamine oxidase A (MAO A) inhibitors decrease glioma progression by Kushal, Swati, Wang, Weijun, Vaikari, Vijaya Pooja, Kota, Rajesh, Chen, Kevin, Yeh, Tzu-Shao, Jhaveri, Niyati, Groshen, Susan L, Olenyuk, Bogdan Z, Chen, Thomas C, Hofman, Florence M, Shih, Jean C

    Published in Oncotarget (22-03-2016)
    “…Glioblastoma (GBM) is an aggressive brain tumor which is currently treated with temozolomide (TMZ). Tumors usually become resistant to TMZ and recur; no…”
    Get full text
    Journal Article
  9. 9

    Tumor Targeting, Trifunctional Dendritic Wedge by Dubey, Ramin, Kushal, Swati, Mollard, Alexis, Vojtovich, Lesya, Oh, Philip, Levin, Michael D, Schnitzer, Jan E, Zharov, Ilya, Olenyuk, Bogdan Z

    Published in Bioconjugate chemistry (21-01-2015)
    “…We report in vitro and in vivo evaluation of a newly designed trifunctional theranostic agent for targeting solid tumors. This agent combines a dendritic wedge…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Abstract 289: Hydrogen bond surrogate (HBS) helices as orthosteric regulator of hypoxia inducible transcription by Kushal, Swati, Bullock, Brooke, Henchey, Laura, Arora, Paramjit, Olenyuk, Bogdan

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract Hypoxia-Inducible Factor (HIF-1) is a heterodimeric transcriptional activator which plays a critical role in tumorigenesis and therefore is an…”
    Get full text
    Journal Article
  12. 12

    Synthetic Small Molecules and Protein Secondary Structure Mimetics as Modulators of Hypoxia-Inducible Transcription and Integrin Receptors Function by Kushal, Swati

    Published 01-01-2013
    “…Transcription factors are the key regulators of cancer gene expression and play a critical role in every aspect of tumorigenesis. Despite their relevance in…”
    Get full text
    Dissertation
  13. 13
  14. 14

    Inhibition of hypoxia-inducible transcription factor complex with designed epipolythiodiketopiperazine by Kushal, Swati, Wang, Hui, László, Csaba F., Szábo, Lajos Z., Olenyuk, Bogdan Z.

    Published in Biopolymers (01-01-2011)
    “…Designed small molecule inhibitors of hypoxia‐inducible gene expression have potential to become new research tools for molecular biology, genetics and serve…”
    Get full text
    Journal Article